Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

• Publication date: October 2012
• Report size: 89 pages

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Summary GlobalData’s new report, “Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market...

Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018



Summary



GlobalData’s new report, “Vertebral Augmentation and Vertebroplasty Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018” provides key data, information and analysis on the global vertebral augmentation and vertebroplasty devices market. The report provides market landscape, competitive landscape and market trends information on the vertebral augmentation and vertebroplasty devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.



Scope


- Key geographies covered include the US, the UK, Germany, France, Italy, Spain and Japan.
- Key segments covered include vertebral augmentation and vertebroplasty devices.
- Annualized market revenues data from 2004 to 2011, forecast forward for seven years to 2018. Company shares data for 2011.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within vertebral augmentation and vertebroplasty devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Stryker and CareFusion



Reasons to buy


- Develop business strategies by understanding the trends and developments that are driving the vertebral augmentation and vertebroplasty devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next big thing in the vertebral augmentation and vertebroplasty devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global vertebral augmentation and vertebroplasty devices market and the factors shaping it.

Marketing Industry in Europe

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 GlobalData Report Guidance 8
3 Vertebral Compression Fractures - Overview 9
3.1 Epidemiology 9
3.2 Acute and Chronic Symptoms 10
3.3 Treatment Options for VCF 11
3.3.1 Benefits of Vertebral Augmentation over Vertebroplasty 13
3.3.2 Potential Complications 13
3.4 Treatment Flow Model for Vertebral Augmentation and Vertebroplasty Devices 13
4 Vertebral Augmentation and Vertebroplasty Devices: Global Market Characterization 15
4.1 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Historic, 2004–2011 15
4.2 Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), Forecast, 2011–2018 16
4.3 Vertebral Augmentation and Vertebroplasty Devices Market, Key Trends 18
4.3.1 Recovery of Kyphoplasty and Vertebroplasty Market from Negative Impact of New England Journal of Medicine Studies 18
4.3.2 Niche Status of Vertebral Augmentation Market with High Growth and Low Competition Provides a Great Opportunity for Orthopedic Device Manufacturers 22
4.3.3 Ongoing Studies Comparing the Effectiveness of Vertebral Augmentation and Vertebroplasty Techniques might decide the Course of Future Industry Growth 23
4.4 Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
4.4.1 Market Drivers 30
4.4.2 Market Restraints 38
5 Vertebral Augmentation and Vertebroplasty Devices Market, Analysis by Country, Revenue ($m), 2004 – 2018 42
5.1 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Historic, 2004–2011 42
5.2 Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), Forecast, 2011–2018 43
5.3 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Historic, 2004–2011 45
5.4 Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), Forecast, 2011–2018 46
5.5 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Historic, 2004–2011 47
5.6 Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), Forecast, 2011–2018 48
5.7 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Historic, 2004–2011 49
5.8 Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), Forecast, 2011–2018 51
5.9 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Historic, 2004–2011 52
5.10 Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), Forecast, 2011–2018 53
5.11 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Historic, 2004–2011 54
5.12 Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), Forecast, 2011–2018 55
5.13 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Historic, 2004–2011 56
5.14 Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), Forecast, 2011–2018 57
6 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Competitive Assessment 59
6.1 Vertebral Augmentation and Vertebroplasty Devices, Key Market Participants 60
6.1.1 Medtronic Inc. 60
6.1.2 Stryker Corporation 65
6.1.3 CareFusion 67
7 Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products 70
7.1 Confidence Spinal Cement System, Johnson & Johnson (DePuy/Synthes) 70
7.1.1 Product Description 70
7.2 Shield Kyphoplasty System, Soteira 71
7.2.1 Product Description 71
7.3 Kyphoplasty System, BONESUPPORT 71
7.3.1 Product Description 71
7.4 Acu-Cut Vertebral Augmentation System, Ascendx Spine 71
7.4.1 Product Description 71
7.5 V-MAX Delivery System, Johnson & Johnson (DePuy/Synthes) 72
7.5.1 Product Description 72
7.6 Integrated System for Vertebroplasty, Skeltex 72
7.6.1 Product Description 72
7.7 OsseoFix Spinal Fracture Reduction System, Alphatec Spine 72
7.7.1 Product Description 72
8 Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products 73
8.1 Crosstrees Pod, Crosstrees Medical Inc. 73
8.1.1 Product Description 73
8.1.2 Product Status 73
8.2 Kiva VCF System, Benvenue Medical, Inc. 74
8.2.1 Product Description 74
8.2.2 Product Status 74
8.3 OsseoFix Spinal Fracture Reduction System, Alphatec Spine, Inc. 74
8.3.1 Product Description 74
8.3.2 Product Status 74
8.4 VerteLift Implant, SpineAlign Medical, Inc. 74
8.4.1 Product Description 74
8.4.2 Product Status 74
8.5 AVAMAX Vertebroplasty Kits, CareFusion 75
8.5.1 Product Description 75
8.5.2 Product Status 75
9 Vertebral Augmentation and Vertebroplasty Devices Market: Strategic Deals Analysis 76
9.1 List of Venture Financing Deals 77
9.2 List of Debt Offerings 79
9.3 List of Partnership Deals 80
9.4 List of Equity Offerings Deals 80
9.5 Key Deals 80
9.5.1 Ascendx Spine Entered into Co-Marketing Agreement with Anwerina 80
9.5.2 Benvenue Medical Raised $25m Series D Financing 81
9.5.3 Shanghai Kinetic Medical Completed IPO for $60m 81
10 Appendix 82
10.1 Market Definitions 82
10.1.1 Vertebral Augmentation and Vertebroplasty Devices 82
10.2 Acronyms 82
10.3 Sources 83
10.4 Research Methodology 87
10.4.1 Secondary Research 88
10.4.2 Primary Research 88
10.4.3 Models 88
10.4.4 Forecasts 89
10.4.5 Expert Panels 89
10.5 GlobalData Consulting 89
10.6 Contact Us 89
10.7 Disclaimer 89

1.1 List of Tables

Table 1: VCF Prevalence in Cancer Patients 10
Table 2: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004–2011 15
Table 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011–2018 17
Table 4: Details of New England Journal of Medicine Studies on Vertebroplasty And Vertebral Augmentation Procedures, August 2009 18
Table 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008–2010 19
Table 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008–2011 21
Table 7: FREE (Fracture Reduction Evaluation), 2009 23
Table 8: FREE (Fracture Reduction Evaluation), 2011 24
Table 9: Cancer Patient Fracture Evaluation or CAFÉ, 2011 24
Table 10: Mortality Risk for Operated and Non-operated Vertebral Fracture Patients in the Medicare population or The SAVE study, 2011 25
Table 11: Three-year Outcomes after Kyphoplasty in Patients with Osteoporosis with Painful Vertebral Fractures , 2010 25
Table 12: Comparison of 5,766 Vertebral Compression Fractures Treated With or Without Kyphoplasty, 2010 26
Table 13: The Kiva System as a Vertebral Augmentation Treatment (KAST), Ongoing 27
Table 14: Balloon Kyphoplasty Versus Vertebroplasty for Treatment of Osteoporotic Vertebral Compression Fracture: a Prospective, Comparative and Randomized Clinical Study 27
Table 15: Adjacent Vertebral Fractures after Percutaneous Vertebral Augmentation of Osteoporotic Vertebral Compression Fracture: A Comparison of Balloon Kyphoplasty and Vertebroplasty, 2010 28
Table 16: Efficacy of Unipedicular Balloon Kyphoplasty for Treatment of Multiple Myeloma Vertebral Lesions, 2011 28
Table 17: Snapshot of New Diagnostic Technologies for Osteoporosis, 2010–2012 31
Table 18: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011–2018 35
Table 19: Procedure Cost Comparison, Vertebroplasty vs. Vertebral Augmentation, the US, 2007–2008 36
Table 20: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011 40
Table 21: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004–2011 42
Table 22: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011–2018 44
Table 23: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004–2011 45
Table 24: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011–2018 46
Table 25: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004–2011 47
Table 26: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011–2018 48
Table 27: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004–2011 50
Table 28: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011–2018 51
Table 29: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004–2011 52
Table 30: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011–2018 53
Table 31: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($), 2004–2011 54
Table 32: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011–2018 55
Table 33: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004–2011 56
Table 34: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011–2018 58
Table 35: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011 59
Table 36: Medtronic, Key Marketed Products, 2012 60
Table 37: Kyphoplasty Settlements Between Hospitals and US Federal Government, 2009 ? 2011 62
Table 38: Medtronic, Quarterly Revenue Decline from Core Spine, 2012 63
Table 39: Stryker, Key Marketed Products, 2012 65
Table 40: CareFusion, Key Marketed Products, 2012 68
Table 41: Vertebral Augmentation and Vertebroplasty Devices: Other Marketed Products 70
Table 42: Confidence Spinal Cement System, Description, 2011 70
Table 43: Shield Kyphoplasty System, Description, 2011 71
Table 44: Kyphoplasty System, Description, 2011 71
Table 45: Acu-Cut Vertebral Augmentation System, Description, 2011 71
Table 46: V-MAX Delivery System, Description, 2011 72
Table 47: Integrated System for Vertebroplasty (ISV), Description, 2011 72
Table 48: OsseoFix Spinal Fracture Reduction System, Description, 2010 72
Table 49: Vertebral Augmentation and Vertebroplasty Devices: Key Pipeline Products 73
Table 50: Crosstrees Pod, Status 73
Table 51: Kiva VCF System, Status 74
Table 52: OsseoFix Spinal Fracture Reduction System, Status 74
Table 53: VerteLift Implant 74
Table 54: AVAMAX Vertebroplasty Kits, Status 75
Table 55: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010–2012 76
Table 56: Vertebral Augmentation and Vertebroplasty Devices Market, Venture Financing Deals, 2010–2012 77
Table 57: Vertebral Augmentation and Vertebroplasty Devices Market, Debt Offerings, 2010–2012 79
Table 58: Vertebral Augmentation and Vertebroplasty Devices Market, Partnership Deals, 2010–2012 80
Table 59: Vertebral Augmentation and Vertebroplasty Devices Market, Equity Offering Deals, 2012 80

1.2 List of Figures

Figure 1: Vertebral Compression Fracture, Treatment Options 11
Figure 2: Treatment Flow Model: Vertebral Augmentation and Vertebroplasty Devices, Global, 2010 13
Figure 3: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2004–2011 15
Figure 4: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Revenue ($m), 2011–2018 16
Figure 5: Global Procedure Volume for Vertebral Augmentation and Vertebroplasty, 2008–2010 19
Figure 6: Global Kyphoplasty and Vertebroplasty Market Recovery Pattern, 2008–2011 21
Figure 7: Global Vertebral Augmentation and Vertebroplasty Devices, Market Dynamics 29
Figure 8: Vertebral Augmentation Devices Market, Japan, Revenue ($m), Forecast, 2011–2018 35
Figure 9: Vertebral Augmentation and Vertebroplasty Devices Market, by Country, Europe, Revenue ($m), 2011 39
Figure 10: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2004–2011 42
Figure 11: Vertebral Augmentation and Vertebroplasty Devices Market, the US, Revenue ($m), 2011–2018 43
Figure 12: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2004–2011 45
Figure 13: Vertebral Augmentation and Vertebroplasty Devices Market, the UK, Revenue ($m), 2011–2018 46
Figure 14: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2004–2011 47
Figure 15: Vertebral Augmentation and Vertebroplasty Devices Market, Germany, Revenue ($m), 2011–2018 48
Figure 16: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2004–2011 49
Figure 17: Vertebral Augmentation and Vertebroplasty Devices Market, France, Revenue ($m), 2011–2018 51
Figure 18: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2004–2011 52
Figure 19: Vertebral Augmentation and Vertebroplasty Devices Market, Italy, Revenue ($m), 2011–2018 53
Figure 20: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2004–2011 54
Figure 21: Vertebral Augmentation and Vertebroplasty Devices Market, Spain, Revenue ($m), 2011–2018 55
Figure 22: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2004–2011 56
Figure 23: Vertebral Augmentation and Vertebroplasty Devices Market, Japan, Revenue ($m), 2011–2018 57
Figure 24: Vertebral Augmentation and Vertebroplasty Devices Market, Global, Company Share (%), 2011 59
Figure 25: Medtronic, SWOT Analysis 61
Figure 26: Medtronic, Quarterly Revenue Decline from Core Spine, 2012 63
Figure 27: Stryker, SWOT Analysis 65
Figure 28: CareFusion, SWOT Analysis 68
Figure 29: Vertebral Augmentation and Vertebroplasty Devices Market, Key Strategic Deals Analysis, 2010–2012 76

Companies mentioned
Medtronic Inc.
Stryker Corporation
CareFusion